• PDF: Delivered by email usually within 48 UK business hours.

Middle East and Africa Drug Delivery Devices Market Outlook to 2018
Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Others

  • Publication Date:January 2013
  • Publisher:GlobalData
  • Product Type: Report
  • Pages:102

Middle East and Africa Drug Delivery Devices Market Outlook to 2018 Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Others

Middle East and Africa Drug Delivery Devices Market Outlook to 2018 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Others

Summary

GlobalData's new report, 'Middle East and Africa Drug Delivery Devices Market Outlook to 2018 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Others' provides key market data on the Middle East and Africa Drug Delivery Devices market - South Africa, Saudi Arabia and Israel.. The report provides value (USD million) data for all the market categories - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate - level profiles of the key market participants.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in - house analysis by GlobalData's team of industry experts.

Scope

  • Countries covered include South Africa, Saudi Arabia and Israel..
  • Market size and company share data for Drug Delivery Devices market categories - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections.
  • Annualized market revenues (USD million) data for each of the market categories in each of the country. Data from 2004 to 2011, forecast forward for 7 years to 2018.
  • 2011 company shares and distribution shares data for each of the market categories and countries.
  • Global corporate - level profiles of key companies operating within the Middle East and Africa Drug Delivery Devices market.
  • Key players covered include GlaxoSmithKline plc, AstraZeneca PLC, Boehringer Ingelheim GmbH, Cipla Medpro (Pty) Ltd., Hospira, Inc. and Baxter International Inc.

Reasons to buy

  • Develop business strategies by identifying the key market categories and segments poised for strong growth.
  • Develop market - entry and market expansion strategies.
  • Design competition strategies by identifying who - stands - where in the Middle East and Africa Drug Delivery Devices competitive landscape.
  • Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • What are the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize.
  • 2 Introduction
    • 2.1 What is This Report About?
  • 3 Drug Delivery Devices in Middle East and Africa
    • 3.1 Drug Delivery Devices Cross Country Comparison, Revenue ($m), USD Constant, 2004 - 2018
    • 3.2 Drug Delivery Devices, Middle East and Africa, Overall Revenue ($m), USD Constant, 2004 - 2018
    • 3.3 Drug Delivery Devices, Middle East and Africa, Company share (2010 - 2011)
  • 4 Drug Delivery Devices In South Africa
    • 4.1 Drug Delivery Devices, South Africa, Overall Revenue ($m), USD Constant, 2004 - 2018
    • 4.2 Drug Delivery Devices, South Africa, Distribution Share (2010 - 2011)
      • 4.2.1 Central Venous Catheters, South Africa, Distribution Share (2010 - 2011)
      • 4.2.2 Infusion Systems, South Africa, Distribution Share (2010 - 2011)
      • 4.2.3 Metered Dose Inhaler Devices, South Africa, Distribution Share (2010 - 2011)
      • 4.2.4 Needle Free Injections, South Africa, Distribution Share (2010 - 2011)
    • 4.3 Drug Delivery Devices, South Africa, Company Share (2010 - 2011)
      • 4.3.1 Drug Delivery Devices, South Africa, Company Share (2010 - 2011)
      • 4.3.2 Central Venous Catheters, South Africa, Company Share (2010 - 2011)
      • 4.3.3 Infusion Systems, South Africa, Company Share (2010 - 2011)
      • 4.3.4 Metered Dose Inhaler Devices, South Africa, Company Share (2010 - 2011)
      • 4.3.5 Needle Free Injections, South Africa, Company Share (2010 - 2011)
  • 5 Drug Delivery Devices In Israel
    • 5.1 Drug Delivery Devices, Israel, Overall Revenue ($m), USD Constant, 2004 - 2018
    • 5.2 Drug Delivery Devices, Israel, Distribution Share (2010 - 2011)
      • 5.2.1 Central Venous Catheters, Israel, Distribution Share (2010 - 2011)
      • 5.2.2 Infusion Systems, Israel, Distribution Share (2010 - 2011)
      • 5.2.3 Metered Dose Inhaler Devices, Israel, Distribution Share (2010 - 2011)
      • 5.2.4 Needle Free Injections, Israel, Distribution Share (2010 - 2011)
    • 5.3 Drug Delivery Devices, Israel, Company Share (2010 - 2011)
      • 5.3.1 Drug Delivery Devices, Israel, Company Share (2010 - 2011)
      • 5.3.2 Central Venous Catheters, Israel, Company Share (2010 - 2011)
      • 5.3.3 Infusion Systems, Israel, Company Share (2010 - 2011)
      • 5.3.4 Metered Dose Inhaler Devices, Israel, Company Share (2010 - 2011)
      • 5.3.5 Needle Free Injections, Israel, Company Share (2010 - 2011)
  • 6 Drug Delivery Devices In Saudi Arabia
    • 6.1 Drug Delivery Devices, Saudi Arabia, Overall Revenue ($m), USD Constant, 2004 - 2018
    • 6.2 Drug Delivery Devices, Saudi Arabia, Distribution Share (2010 - 2011)
      • 6.2.1 Central Venous Catheters, Saudi Arabia, Distribution Share (2010 - 2011)
      • 6.2.2 Infusion Systems, Saudi Arabia, Distribution Share (2010 - 2011)
      • 6.2.3 Metered Dose Inhaler Devices, Saudi Arabia, Distribution Share (2010 - 2011)
      • 6.2.4 Needle Free Injections, Saudi Arabia, Distribution Share (2010 - 2011)
    • 6.3 Drug Delivery Devices, Saudi Arabia, Company Share (2010 - 2011)
      • 6.3.1 Drug Delivery Devices, Saudi Arabia, Company Share (2010 - 2011)
      • 6.3.2 Central Venous Catheters, Saudi Arabia, Company Share (2010 - 2011)
      • 6.3.3 Infusion Systems, Saudi Arabia, Company Share (2010 - 2011)
      • 6.3.4 Metered Dose Inhaler Devices, Saudi Arabia, Company Share (2010 - 2011)
      • 6.3.5 Needle Free Injections, Saudi Arabia, Company Share (2010 - 2011)
  • 7 Overview of Key Companies in Middle East and Africa Drug Delivery Devices Market
    • 7.1 GlaxoSmithKline plc
      • 7.1.1 Company Overview
      • 7.1.2 Share in the Middle East and Africa Drug Delivery Devices Market
    • 7.2 AstraZeneca PLC
      • 7.2.1 Company Overview
      • 7.2.2 Share in the Middle East and Africa Drug Delivery Devices Market
    • 7.3 Boehringer Ingelheim GmbH
      • 7.3.1 Company Overview
      • 7.3.2 Share in the Middle East and Africa Drug Delivery Devices Market
    • 7.4 Cipla Medpro (Pty) Ltd.
      • 7.4.1 Company Overview
      • 7.4.2 Share in the Middle East and Africa Drug Delivery Devices Market
    • 7.5 Hospira, Inc.
      • 7.5.1 Company Overview
      • 7.5.2 Share in the Middle East and Africa Drug Delivery Devices Market
    • 7.6 Baxter International Inc.
      • 7.6.1 Company Overview
      • 7.6.2 Share in the Middle East and Africa Drug Delivery Devices Market
    • 7.7 B. Braun Melsungen AG
      • 7.7.1 Company Overview
    • 7.8 Fresenius Kabi AG
      • 7.8.1 Company Overview
    • 7.9 Medtronic, Inc.
      • 7.9.1 Company Overview
    • 7.10 Smiths Medical
      • 7.10.1 Company Overview
    • 7.11 Terumo Corporation
      • 7.11.1 Company Overview
    • 7.12 CareFusion Corporation
      • 7.12.1 Company Overview
    • 7.13 3M Health Care Ltd.
      • 7.13.1 Company Overview
    • 7.14 Arcomed AG
      • 7.14.1 Company Overview
    • 7.15 Consort Medical plc
      • 7.15.1 Company Overview
    • 7.16 Edwards Lifesciences Corporation
      • 7.16.1 Company Overview
    • 7.17 Teleflex Incorporated
      • 7.17.1 Company Overview
    • 7.18 Universal Medical Technologies Inc.
      • 7.18.1 Company Overview
    • 7.19 INJEX - Equidyne Systems
      • 7.19.1 Company Overview
    • 7.20 Nipro Corporation
      • 7.20.1 Company Overview
    • 7.21 C. R. Bard, Inc.
      • 7.21.1 Company Overview
    • 7.22 Becton, Dickinson and Company
      • 7.22.1 Company Overview
    • 7.23 Cook Medical Incorporated
      • 7.23.1 Company Overview
    • 7.24 Samtronic
      • 7.24.1 Company Overview
    • 7.25 PharmaJet, Inc.
      • 7.25.1 Company Overview
    • 7.26 Lifemed Ind. de Equipamentos e Art. Medicos Hospitalares S.A
      • 7.26.1 Company Overview
  • 8 Drug Delivery Devices Market Pipeline Products
  • 9 Financial Deals Landscape
    • 9.1 Acquisition
      • 9.1.1 D. Medical Industries To Acquire Diabetes Device Company
      • 9.1.2 Syneron Medical To Acquire TransPharma Medical For $3.6 Million
      • 9.1.3 Paladin Labs Completes Acquisition Of 44.52% Stake In Litha Healthcare Group For $26.2 Million
    • 9.2 Partnerships
      • 9.2.1 NanoPass Technologies Enters Into Licensing Agreement With Janssen Pharma For MicronJet
      • 9.2.2 Monosol Enters Into Agreement With BiondVax To Develop Oral Delivery For Flu Vaccine
      • 9.2.3 Medisafe 1 Technologies Enters Into Licensing Agreement With SafeCode Drug Technologies For Patents
  • 10 Recent Developments
    • 10.1 Strategy And Business Planning
      • 10.1.1 Aug 24, 2012: Sandoz Supports Zambian Government's Health Shops Initiative To Increase Access To Affordable High - quality Medicines
    • 10.2 Legal and Regulatory
      • 10.2.1 Apr 26, 2012: Antares Pharma Announces Epinephrine Auto - Injector Settlement Agreement Between Teva And Meridian Medical
  • 11 Appendix
    • 11.1 Definitions of Markets Covered in the Report
      • 11.1.1 Drug Delivery Devices
    • 11.2 Research Methodology
    • 11.3 Secondary Research
    • 11.4 Primary Research
    • 11.5 Models
    • 11.6 Forecasts
    • 11.7 Expert Panels
    • 11.8 GlobalData Consulting
    • 11.9 Currency Conversion
    • 11.10 Contact Us
    • 11.11 Disclaimer
  • 1.1 List of Tables
    • Table 1: Drug Delivery Devices, Cross Country Comparison, Revenue ($m),USD Constant, 2004 - 2018
    • Table 2: Drug Delivery Devices, Middle East and Africa, Overall Revenue ($m), USD Constant, 2004 - 2018
    • Table 3: Drug Delivery Devices, Middle East and Africa, Cross - Category Analysis, 2004 - 2018
    • Table 4: Drug Delivery Devices, Middle East and Africa, Overall Revenue ($m), USD Constant, Historic, 2004 - 2011
    • Table 5: Drug Delivery Devices, Middle East and Africa, Overall Revenue ($m), USD Constant, Forecast, 2011 - 2018
    • Table 6: Drug Delivery Devices, Middle East and Africa, Company share by Revenue ($m), USD Constant, 2010 - 2011
    • Table 7: Drug Delivery Devices, South Africa, Overall Revenue ($m), USD Constant, 2004 - 2018
    • Table 8: Drug Delivery Devices, South Africa, Overall Revenue ($m), USD Constant, Historic, 2004 - 2011
    • Table 9: Drug Delivery Devices, South Africa, Overall Revenue ($m), USD Constant, Forecast, 2011 - 2018
    • Table 10: Central Venous Catheters, South Africa, Distribution Share by Revenue ($m), USD Constant, 2010 - 2011
    • Table 11: Infusion Systems, South Africa, Distribution Share by Revenue ($m), USD Constant, 2010 - 2011
    • Table 12: Metered Dose Inhaler Devices, South Africa, Distribution Share by Revenue ($m), USD Constant, 2010 - 2011
    • Table 13: Needle Free Injections, South Africa, Distribution Share by Revenue ($m), USD Constant, 2010 - 2011
    • Table 14: Drug Delivery Devices, South Africa, Company Share by Revenue ($m), USD Constant, 2010 - 2011
    • Table 15: Central Venous Catheters, South Africa, Company Share by Revenue ($m), USD Constant, 2010 - 2011
    • Table 16: Infusion Systems, South Africa, Company Share by Revenue ($m), USD Constant, 2010 - 2011
    • Table 17: Metered Dose Inhaler Devices, South Africa, Company Share by Revenue ($m), USD Constant, 2010 - 2011
    • Table 18: Needle Free Injections, South Africa, Company Share by Revenue ($m), USD Constant, 2010 - 2011
    • Table 19: Drug Delivery Devices, Israel, Overall Revenue ($m), USD Constant, 2004 - 2018
    • Table 20: Drug Delivery Devices, Israel, Overall Revenue ($m), USD Constant, Historic, 2004 - 2011
    • Table 21: Drug Delivery Devices, Israel, Overall Revenue ($m), USD Constant, Forecast, 2011 - 2018
    • Table 22: Central Venous Catheters, Israel, Distribution Share by Revenue ($m), USD Constant, 2010 - 2011
    • Table 23: Infusion Systems, Israel, Distribution Share by Revenue ($m), USD Constant, 2010 - 2011
    • Table 24: Metered Dose Inhaler Devices, Israel, Distribution Share by Revenue ($m), USD Constant, 2010 - 2011
    • Table 25: Needle Free Injections, Israel, Distribution Share by Revenue ($m), USD Constant, 2010 - 2011
    • Table 26: Drug Delivery Devices, Israel, Company Share by Revenue ($m), USD Constant, 2010 - 2011
    • Table 27: Central Venous Catheters, Israel, Company Share by Revenue ($m), USD Constant, 2010 - 2011
    • Table 28: Infusion Systems, Israel, Company Share by Revenue ($m), USD Constant, 2010 - 2011
    • Table 29: Metered Dose Inhaler Devices, Israel, Company Share by Revenue ($m), USD Constant, 2010 - 2011
    • Table 30: Needle Free Injections, Israel, Company Share by Revenue ($m), USD Constant, 2010 - 2011
    • Table 31: Drug Delivery Devices, Saudi Arabia, Overall Revenue ($m), USD Constant, 2004 - 2018
    • Table 32: Drug Delivery Devices, Saudi Arabia, Overall Revenue ($m), USD Constant, Historic, 2004 - 2011
    • Table 33: Drug Delivery Devices, Saudi Arabia, Overall Revenue ($m), USD Constant, Forecast, 2011 - 2018
    • Table 34: Central Venous Catheters, Saudi Arabia, Distribution Share by Revenue ($m), USD Constant, 2010 - 2011
    • Table 35: Infusion Systems, Saudi Arabia, Distribution Share by Revenue ($m), USD Constant, 2010 - 2011
    • Table 36: Metered Dose Inhaler Devices, Saudi Arabia, Distribution Share by Revenue ($m), USD Constant, 2010 - 2011
    • Table 37: Needle Free Injections, Saudi Arabia, Distribution Share by Revenue ($m), USD Constant, 2010 - 2011
    • Table 38: Drug Delivery Devices, Saudi Arabia, Company Share by Revenue ($m), USD Constant, 2010 - 2011
    • Table 39: Central Venous Catheters, Saudi Arabia, Company Share by Revenue ($m), USD Constant, 2010 - 2011
    • Table 40: Infusion Systems, Saudi Arabia, Company Share by Revenue ($m), USD Constant, 2010 - 2011
    • Table 41: Metered Dose Inhaler Devices, Saudi Arabia, Company Share by Revenue ($m), USD Constant, 2010 - 2011
    • Table 42: Needle Free Injections, Saudi Arabia, Company Share by Revenue ($m), USD Constant, 2010 - 2011
    • Table 43: Drug Delivery Devices Market Pipeline Products
    • Table 44: D. Medical Industries To Acquire Diabetes Device Company
    • Table 45: Syneron Medical To Acquire TransPharma Medical For $3.6 Million
    • Table 46: Paladin Labs Completes Acquisition Of 44.52% Stake In Litha Healthcare Group For $26.2 Million
    • Table 47: NanoPass Technologies Enters Into Licensing Agreement With Janssen Pharma For MicronJet
    • Table 48: Monosol Enters Into Agreement With BiondVax To Develop Oral Delivery For Flu Vaccine
    • Table 49: Medisafe 1 Technologies Enters Into Licensing Agreement With SafeCode Drug Technologies For Patents
  • 1.2 List of Figures
    • Figure 1: Drug Delivery Devices, Cross Country Comparison, Revenue ($m), USD Constant, 2004 - 2018
    • Figure 2: Drug Delivery Devices, Middle East and Africa, Overall Revenue ($m), USD Constant, 2004 - 2018
    • Figure 3: Drug Delivery Devices, Middle East and Africa, Cross - Category Analysis, by Revenue ($m), USD Constant, 2004 - 2018
    • Figure 4: Drug Delivery Devices, Middle East and Africa, Overall Revenue ($m), USD Constant, Historic, 2004 - 2011
    • Figure 5: Drug Delivery Devices, Middle East and Africa, Overall Revenue ($m), USD Constant, Forecast, 2011 - 2018
    • Figure 6: Drug Delivery Devices, Middle East and Africa, Company share (%), 2011
    • Figure 7: Drug Delivery Devices, South Africa, Overall Revenue ($m), USD Constant, 2004 - 2018
    • Figure 8: Drug Delivery Devices, South Africa, Overall Revenue ($m), USD Constant, Historic, 2004 - 2011
    • Figure 9: Drug Delivery Devices, South Africa, Overall Revenue ($m), USD Constant, Forecast, 2011 - 2018
    • Figure 10: Drug Delivery Devices, South Africa, Company Share (%), 2011
    • Figure 11: Central Venous Catheters, South Africa, Company Share (%), 2011
    • Figure 12: Infusion Systems, South Africa, Company Share (%), 2011
    • Figure 13: Metered Dose Inhaler Devices, South Africa, Company Share (%), 2011
    • Figure 14: Needle Free Injections, South Africa, Company Share (%), 2011
    • Figure 15: Drug Delivery Devices, Israel, Overall Revenue ($m), USD Constant, 2004 - 2018
    • Figure 16: Drug Delivery Devices, Israel, Overall Revenue ($m), USD Constant, Historic, 2004 - 2011
    • Figure 17: Drug Delivery Devices, Israel, Overall Revenue ($m), USD Constant, Forecast, 2011 - 2018
    • Figure 18: Drug Delivery Devices, Israel, Company Share (%), 2011
    • Figure 19: Central Venous Catheters, Israel, Company Share (%), 2011
    • Figure 20: Infusion Systems, Israel, Company Share (%), 2011
    • Figure 21: Metered Dose Inhaler Devices, Israel, Company Share (%), 2011
    • Figure 22: Needle Free Injections, Israel, Company Share (%), 2011
    • Figure 23: Drug Delivery Devices, Saudi Arabia, Overall Revenue ($m), USD Constant, 2004 - 2018
    • Figure 24: Drug Delivery Devices, Saudi Arabia, Overall Revenue ($m), USD Constant, Historic, 2004 - 2011
    • Figure 25: Drug Delivery Devices, Saudi Arabia, Overall Revenue ($m), USD Constant, Forecast, 2011 - 2018
    • Figure 26: Drug Delivery Devices, Saudi Arabia, Company Share (%), 2011
    • Figure 27: Central Venous Catheters, Saudi Arabia, Company Share (%), 2011
    • Figure 28: Infusion Systems, Saudi Arabia, Company Share (%), 2011
    • Figure 29: Metered Dose Inhaler Devices, Saudi Arabia, Company Share (%), 2011
    • Figure 30: Needle Free Injections, Saudi Arabia, Company Share (%), 2011
    • Figure 31: GlaxoSmithKline plc, Company Share (%), Middle East and Africa Drug Delivery Devices Market, 2011
    • Figure 32: AstraZeneca PLC, Company Share (%), Middle East and Africa Drug Delivery Devices Market, 2011
    • Figure 33: Boehringer Ingelheim GmbH, Company Share (%), Middle East and Africa Drug Delivery Devices Market, 2011
    • Figure 34: Cipla Medpro (Pty) Ltd., Company Share (%), Middle East and Africa Drug Delivery Devices Market, 2011
    • Figure 35: Hospira, Inc., Company Share (%), Middle East and Africa Drug Delivery Devices Market, 2011
    • Figure 36: Baxter International Inc., Company Share (%), Middle East and Africa Drug Delivery Devices Market, 2011
+44 20 8816 8548

Ask a question about Middle East and Africa Drug Delivery Devices Market Outlook to 2018

Enter the characters you see in the picture below
Captcha